Recurrent Secondary Acute Myeloid Leukemia
2 clinical trials · Condition
◉ Watch Recurrent Secondary Acute Myeloid Leukemia
| Record | Firm | Date |
|---|---|---|
| Ruxolitinib in Combination With Venetoclax With and Without Azacitidine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia (NCT03874052) | Jennifer Saultz | 2019-08-16 |
Track Recurrent Secondary Acute Myeloid Leukemia automatically
Every clearance here is in the API, with alerts when new ones post.